Published in Virology on March 01, 1970
Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol (1974) 3.37
Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci U S A (1976) 2.14
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol (1976) 1.69
Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA. J Virol (1981) 1.17
Studies on the budding process of a temperature-sensitive mutant of murine leukemia virus with a scanning electron microscope. J Virol (1975) 1.17
Structural rearrangement and subunit composition of RNA from released Soehner-Dmochowski murine sarcoma virions. J Virol (1973) 1.11
Properties of feline leukemia virus. III. Analysis of the RNA. J Virol (1975) 1.03
Chromatographic analyses of isoaccepting tRNAs from avian myeloblastosis virus. J Virol (1973) 1.00
Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J Virol (1997) 0.98
Evidence for a DNA replicative genome for RNA-containing tumor viruses. Proc Natl Acad Sci U S A (1970) 0.84
Role of mitochondria in the production of RNA-containing tumor viruses. J Virol (1973) 0.75
Analysis of the ribonucleic acid of murine leukemia virus. J Virol (1969) 4.32
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 2.16
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
Viral ribonucleic acid polymerase: chick-embryo cells infected with vesicular stomatitis virus or Rous-associated virus. Biochim Biophys Acta (1965) 1.71
Metabolic requirements for infection by Rous sarcoma virus. I. The transient requirement for DNA synthesis. Virology (1966) 1.69
Electron microscopic observations on the ribonucleic acid of murine leukemia virus. J Virol (1969) 1.67
Inhibitors of glycosylation reverse retroviral interference. Virology (1982) 1.64
Control of acute Zollinger-Ellison syndrome with intravenous omeprazole. Lancet (1982) 1.63
Studies on the fixation and development of cellular transformation by Rous sarcoma virus. Virology (1968) 1.57
Induction of mutations in an RNA tumour virus by an analogue of a DNA precursor. Nat New Biol (1971) 1.46
A change in growth potential of cells after conversion by Rous sarcoma virus. J Cell Physiol (1967) 1.45
Characteristics of cores of avian leuko-sarcoma viruses. Virology (1970) 1.36
Accumulation of water during transformation of cells by an avian sarcoma virus. Cell (1974) 1.35
Production of virus by mammalian cells tranformed by Rous sarcoma and murine sarcoma viruses. J Virol (1968) 1.34
Transformation by murine sarcoma virus: fixation (deoxyribonucleic acid synthesis) and development. J Virol (1968) 1.28
The safety profile of De-Nol. Digestion (1987) 1.26
Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res (1968) 1.17
Adenosylhomocysteine hydrolase inhibitors: synthesis of 5'-deoxy-5'-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virus. Biochem Biophys Res Commun (1978) 1.15
Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1. AIDS Res Hum Retroviruses (1997) 1.12
The uptake of nucleosides by cells in culture. I. Inhibition by heterologous nucleosides. Biochim Biophys Acta (1969) 1.04
3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology (1978) 1.03
Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals. Adv Pharmacol (1995) 1.02
Metabolic requirements for infection by Rous sarcoma virus. 3. The synthesis on viral DNA. Virology (1972) 0.98
Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob Agents Chemother (1997) 0.97
Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Res (1994) 0.97
Electrophoretic determinations of hyaluronate produced by cells in culture. Biochim Biophys Acta (1972) 0.97
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nat Med (1997) 0.96
Studies on the relationship between glycolysis and (Na+ + K+)-ATPase in cultured cells. Biochim Biophys Acta (1984) 0.95
Configurational variants of oncornavirus RNAs. J Virol (1976) 0.94
Screening of colorectal cancer. Dig Dis Sci (1986) 0.94
Metabolic requirements for infection by Rous sarcoma virus. IV. Virus reproduction and cellular transformation without cellular division. Virology (1972) 0.93
Acute gastroduodenal lesions related to severe sepsis. Surg Gynecol Obstet (1976) 0.93
Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93
A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamides. Bioorg Med Chem (1997) 0.93
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor. J Pharmacol Exp Ther (1996) 0.89
The structure of the RNA of RNA-containing tumor viruses. Curr Top Microbiol Immunol (1970) 0.89
Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Antimicrob Agents Chemother (1999) 0.89
[Comparative efficacy of omeprazole and cimetidine in the treatment of duodenal ulcer in the acute stage. A French multicenter, controlled therapeutic trial]. Gastroenterol Clin Biol (1987) 0.88
[Treatment of duodenal and gastric ulcer with cimetidine. A multicenter double-blind trial (author's transl)]. Gastroenterol Clin Biol (1977) 0.88
Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem (1994) 0.88
Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV. Antiviral Res (1995) 0.87
[Histological and cytological study of the tumoral and nontumoral endocrine pancreas in the Zollinger-Ellison syndrome]. Rev Int Hepatol (1966) 0.87
Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene. Antiviral Res (1996) 0.86
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. Leukemia (1995) 0.86
The uptake of nucleosides by cells in culture. II. Inhibition by 2-mercapto-1-(beta-4-pyridethyl)benzimidazole. Biochim Biophys Acta (1969) 0.86
[Collagenous colitis, IgA deficiency, Basedow's disease and atrophic gastritis]. Gastroenterol Clin Biol (1985) 0.85
Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action. J Acquir Immune Defic Syndr (1992) 0.85
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. Virology (1995) 0.85
Evidence for a DNA replicative genome for RNA-containing tumor viruses. Proc Natl Acad Sci U S A (1970) 0.84
Intranuclear degradation of the transformation-inducing protein encoded by avian MC29 virus. J Biol Chem (1986) 0.83
Virus-induced transformation without cell division. Science (1973) 0.83
Metabolic requirements for infection by Rous sarcoma virus. II. The participation of cellular DNA. Virology (1966) 0.83
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program. J Nat Prod (2001) 0.83
[Rat bioassay with urine (PSU) for diagnosis and postoperative follow-up in Zollinger-Ellison syndrome (author's transl)]. Acta Gastroenterol Belg (1973) 0.81
Neural crest cells: temperature-dependent transformation by Rous sarcoma virus. Cell Differ (1979) 0.81
A method for the propagation of large amounts of Rous sarcoma virus. Virology (1968) 0.80
Sodium concentrations affect metabolite uptake and cellular metabolism. J Cell Physiol (1978) 0.79
MC29 virus-coded protein occurs as monomers and dimers in transformed cells. J Virol (1985) 0.79
Polypeptide composition of cell membranes from chick embryo fibroblasts transformed by rous sarcoma virus. Biochim Biophys Acta (1975) 0.78
[Treatment of a case of acute hypercalcemia with furosemide]. Ann Med Interne (Paris) (1971) 0.78
Enzyme induction in mammalian cells defective in 28S ribosomal RNA formation. Nature (1976) 0.78
Mass screening for colorectal cancer: statement of the European Group for Colorectal Cancer Screening. Eur J Cancer Prev (1995) 0.78
Increased glucose uptake capacity of Rous-transformed cells and the relevance of deprivation derepression. Cancer Res (1981) 0.78
Uptake of exogenous metabolites by virus-transformed cells: changes induced by temperature and pH. Arch Biochem Biophys (1976) 0.78
Oncogenes and the mitogenic signal pathway. Important Adv Oncol (1989) 0.77
Transformation of cells by rous sarcoma virus: cytoplasmic vacuolization. J Cell Physiol (1976) 0.77
The efficiency of (Na+ + K+)-ATPase in tumorigenic cells. Biochim Biophys Acta (1983) 0.76
Sodium and rubidium uptake in cells transformed by Rous sarcoma virus. J Cell Physiol (1981) 0.76
Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists. Dig Dis Sci (1986) 0.76
[Epigastric pain and regurgitation: descriptive epidemiology in a representative sample of the adult population of France]. Gastroenterol Clin Biol (1988) 0.75
Cytoplasmic vacuoles of Rous virus transformed cells are organelles involved in cation uptake. J Gen Virol (1978) 0.75
[Strategy in the treatment of gastroduodenal ulcerous disease]. Acquis Med Recent (1980) 0.75
The transforming gene of avian myeloblastosis virus (AMV): nucleotide sequence analysis and identification of its translational product. Haematol Blood Transfus (1983) 0.75
The surgical treatment of peptic ulcer disease. A physician's view. Dig Dis Sci (1985) 0.75
Letter: Gastric-mucosa injury in sepsis. N Engl J Med (1975) 0.75
Incorporation of radioactive proline and fucose in gastric mucosal biopsies. Correlation with histological findings. Clin Physiol Biochem (1984) 0.75
[Treatment of duodenal ulcer outbreak with omeprazole. Results of a multicenter non-controlled study]. Gastroenterol Clin Biol (1984) 0.75
[Recurrent gastrointestinal bleeding due to polypoid cystic gastritis at the site of gastroenterostomy after partial gastrectomy (author's transl)]. Gastroenterol Clin Biol (1978) 0.75
[Methodology of clinical trials of a laxative]. Therapie (1982) 0.75
[Maintenance cimetidine treatment in duodenal ulcer disease. First part: Effect on gastric physiology and clinical efficacy (author's transl)]. Gastroenterol Clin Biol (1980) 0.75
The effect of drugs and secretagogues on the biosynthesis of gastric mucins. Biochem Pharmacol (1978) 0.75
[Ingestion of asbestos and cancer]. Gastroenterol Clin Biol (1978) 0.75
Inhibition of development of transformation by Rous sarcoma virus in cultures of high cell density. J Cell Physiol (1974) 0.75
[First-line exploration: fiberoptic gastroscopy or barium meal? A pragmatic evaluation (author's transl)]. Nouv Presse Med (1981) 0.75
Circadian rhythmicity of the intestinal transit in rats and its disturbance through experimental hyperthyroidism. Scand J Gastroenterol (1974) 0.75
[Chronic alcoholic pancreatitis with severe osteomalcia (author's transl)]. Gastroenterol Clin Biol (1978) 0.75
[Acanthosis nigricans associated with diffuse esophageal papillomatosis]. Nouv Presse Med (1975) 0.75
[Anorectal stenosis related to the taking of suppositories combining dextropropoxyphene and paracetamol (Di-Antalvic)]. Gastroenterol Clin Biol (1984) 0.75
A cooperative study on the detection of colorectal cancer and polyps in France. Cancer Detect Prev (1981) 0.75
[Evaluation by the PABA test of the effects of cimetidine combined with pancreatic extracts in severe pancreatic insufficiency]. Gastroenterol Clin Biol (1983) 0.75
[Gastric and oesophageal investigation with detection of asbest fibers in patients exposed to asbest (author's transl)]. Gastroenterol Clin Biol (1978) 0.75
[Maintenance cimetidine treatment in duodenal ulcer disease. Second part: Side-effects and indications (author's transl)]. Gastroenterol Clin Biol (1980) 0.75
[At what stage is the prevention of rectocolonic cancers?]. Presse Med (1983) 0.75
[In vitro biosynthesis of the macromolecules of gastric mucosa]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.75
[Proceedings: Systemic mastocytosis and the Zollinger-Ellison syndrome]. Schweiz Rundsch Med Prax (1974) 0.75
Management of dental patients who are HIV positive. Evid Rep Technol Assess (Summ) (2001) 0.75
[Acrodermatitis enteropathica in a patient with probable jejunal Crohn's disease treated by total parenteral alimentation. Mechanisms of zinc deficiency (author's transl)]. Gastroenterol Clin Biol (1979) 0.75
Biosynthesis of gastric mucins. In vitro incorporation of radioactive glucose. Connect Tissue Res (1975) 0.75